It is released by cancer cells and binds to endothelial cell receptors (i.e., VEGFR) to stimulate tyrosine kinase activity, which in turn stimulates downstream signal transduction and endothelial cell activation and promotes the generation of abnormal blood vessels [20]. The gene discussed is KDR; the disease is cancer.